Join Dr. Michael Abramoff as he discusses Autonomous Artificial Intelligence and Diabetic Retinopathy: Safety, Efficacy and Equity.
Autonomous Artificial Intelligence and Diabetic Retinopathy: Safety, Efficacy and Equity
Join Dr. Michael Abramoff as he discusses Autonomous Artificial Intelligence and Diabetic Retinopathy: Safety, Efficacy and Equity.